NC
PPH icon

Noked Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Noked Capital’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$9.41K Hold
140,000
– – 1% 17
2022
Q2 		$10.8M Buy
+140,000
New +$10.9M 2.47% 11

Other funds holding PPH

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $1.03B AUM 36.74% 1-Year Est. Return

Noked Capital's PPH Position: Q3 2022 in Review

Noked Capital held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2022 at 140,000 shares worth $9.41K. The position accounts for 1% of the portfolio, ranked #17.

Noked Capital first reported a position in PPH in Q2 2022 and has held it in 2 quarters since. The position peaked at $10.8M in Q2 2022. 86 funds tracked by Wall St. Rank hold PPH as of Q3 2022.

  • Noked Capital held 140,000 shares of VanEck Pharmaceutical ETF worth $9.41K as of Q3 2022.
  • Noked Capital left its VanEck Pharmaceutical ETF share count unchanged in Q3 2022.
  • VanEck Pharmaceutical ETF made up 1% of Noked Capital's portfolio in Q3 2022, its #17 holding.
  • Noked Capital first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 2 quarters since.
  • Noked Capital's VanEck Pharmaceutical ETF position peaked at $10.8M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2022.

Based on Noked Capital's 13F filing for Q3 2022, filed 14 Nov 2022.